BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3967977)

  • 1. Radiation exposure rates near brachytherapy patients containing 137Cs sources.
    Glasgow GP; Walker S; Williams JD
    Health Phys; 1985 Jan; 48(1):97-104. PubMed ID: 3967977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bedside shielding on air-kerma rates around gynecologic intracavitary brachytherapy patients containing 226Ra or 137Cs.
    Papin PJ; Ramsey MJ; LaFontaine RL; LePage RP
    Health Phys; 1990 Apr; 58(4):405-10. PubMed ID: 2323922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An examination of radiation exposure to clinical staff from patients implanted with 137Cs and 192Ir for the treatment of gynecologic malignancies.
    Smith CL; Chu WK; Granville D; Nabity L
    Health Phys; 1998 Mar; 74(3):301-8. PubMed ID: 9482595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple experimentally derived algorithm for computer calculated dose rates associated with 137Cs gynecologic insertions.
    Wrede DE; Dawalibi H
    Acta Radiol Oncol; 1980; 19(1):37-40. PubMed ID: 6246728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Source configuration and dose rates for the Selectron afterloading equipment for gynecologic applicators.
    Grigsby PW; Williamson JF; Perez CA
    Int J Radiat Oncol Biol Phys; 1992; 24(2):321-7. PubMed ID: 1526871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing radiation from brachytherapy patients with a cost-effective bedshield.
    Black RE; Stehlik KJ
    Health Phys; 1989 Jun; 56(6):939-41. PubMed ID: 2498232
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose calculations about shielded gynecological colpostats.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):167-78. PubMed ID: 2380082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation exposure to personnel in departments of gynaecologic oncology in Sweden.
    Forsberg B; Spanne P; Hertzman S
    Acta Oncol; 1987; 26(2):113-23. PubMed ID: 3606866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of 137Cs sources with the Fletcher-Suit gynecological applicator.
    Saylor WL; Dillard M
    Med Phys; 1976; 3(2):117-9. PubMed ID: 1264041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
    Zhang P; Beddar AS; Sibata CH
    Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid-afterloading vaginal cylinder for 137Cs brachytherapy.
    Beach JL; Mendiondo OA; Martin JL
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1053-5. PubMed ID: 1917602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with remote afterloading technique in intracavitary therapy.
    Leung PM
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):157-62. PubMed ID: 6421782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of dose delivery in gynecological brachytherapy.
    Tenhunen M; Lahtinen T; Forss M; Kulmala J; Pitkänen M; Pitkänen U
    Acta Oncol; 1997; 36(5):527-9. PubMed ID: 9292750
    [No Abstract]   [Full Text] [Related]  

  • 14. 137Cs dosimetry table for asymmetric source.
    Waggener R; Lange J; Feldmeier J; Eagan P; Martin S
    Med Phys; 1989; 16(2):305-8. PubMed ID: 2716709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors.
    Yondorf MZ; Schwartz TH; Boockvar JA; Pannullo S; Stieg P; Sabbas A; Pavese A; Trichter S; Nedialkova L; Parashar B; Nori D; Chao KS; Wernicke AG
    Health Phys; 2017 Apr; 112(4):403-408. PubMed ID: 28234701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient template-guided permanent interstitial brachytherapy using
    Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
    Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose rates for brachytherapy applicators using 137Cs sources.
    Sharma SC; Gerbi B; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1893-7. PubMed ID: 528254
    [No Abstract]   [Full Text] [Related]  

  • 19. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies.
    Martinez A; Cox RS; Edmundson GK
    Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):297-305. PubMed ID: 6706724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern curietherapy in gynecology. Experiences of the Oscar Lambret Center].
    Castelain B; Guiot P; Wallez-Dirand B; Rohart J
    Lille Med; 1978; 23(6):447-50. PubMed ID: 682858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.